Tech Grace
Pages
Home
Monday, 27 May 2019
Can Novartis Convince Insurers a $2.1 Million Gene Therapy Is a Great Deal?
Can Novartis Convince Insurers a $2.1 Million Gene Therapy Is a Great Deal?
Getting end payers on board with a seven-figure price for Zolgensma won't be easy.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment